Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The synaptotagmin II pseudogene (ENSG00000261747) is a genomic sequence with high similarity to the functional synaptotagmin II gene (SYT2), but which has accumulated mutations that prevent it from coding for a functional protein[3][1][5]. Pseudogenes are traditionally considered non-functional, though some may play rare regulatory roles in the genome[3][5]. ENSG00000261747 does not encode a protein, is not implicated as a disease cause, is not a drug target, nor does it serve as a clinical biomarker. Research and therapeutic interest focus on the functional SYT2 gene, which encodes synaptotagmin II, a protein involved in synaptic vesicle exocytosis and neurotransmitter release[2][4][6]. If you intended to refer to the functional gene/protein "synaptotagmin II," the proper target would be "synaptotagmin II" (or SYT2), which is a valid synaptic vesicle protein and a research target in neuroscience, not this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Synaptotagmin II pseudogene.